Clinical Trials for Novel Neuromodulation Therapies

NIH UH3  NS119844, “Defining Targets for Tic Detection and Suppression in Tourette Syndrome Deep Brain Stimulation”

Project Period: 9/17/2021 – 9/16/2026

https://clinicaltrials.gov/ct2/show/NCT05371041

https://reporter.nih.gov/search/F9dND3SAOUaspT-25XzjAA/project-details/10290544

NIH UH3 NS109557, “Thalamocortical responsive neurostimulation for the treatment of Lennox-Gastaut Syndrome”

Project Period:  06/01/2021 – 05/31/2026

https://clinicaltrials.gov/ct2/show/NCT05339126

https://reporter.nih.gov/search/9QOSlQTwPkyYvO7r74lnrA/project-details/9958791

NIH UG3/UH3 NS112826, “Thalamic stimulation to prevent impaired consciousness in epilepsy”

Project Period: 9/1/19 – 8/31/24

https://clinicaltrials.gov/ct2/show/NCT04897776

https://reporter.nih.gov/search/SZcSUYlbI0-P0UWJO8uoig/project-details/10017335

NIH R01 NS111019, “Central thalamic deep brain stimulation to regulate arousal and cognition”

Project Period: 4/1/20 – 3/31/24

https://reporter.nih.gov/search/_cMQOq8MSEufRQYnBh_S0A/project-details/10246247

NIH UH3 NS095554, “Central thalamic stimulation for traumatic brain injury”

Project Period: 9/20/15 – 8/31/22

https://clinicaltrials.gov/ct2/show/NCT02881151

https://reporter.nih.gov/search/xUU7Szt87EeXE_IpxgBldQ/project-details/10246247